(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

“…This decrease was larger in the disconnected than in the contralateral cortex. …”

Map of Pakistan with marked Punjab province. by Sumaira Sumaira (21453523)

Biases in larger populations. by Sander W. Keemink (21253563)

“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes. by Emma F. Magavern (20947928)

Subjects:

The Ka/Ks values of PtWRKY paralogous gene pairs. by Yuzhao Ma (12840632)

PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013). by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

Conditional ablation of <i>Ybx1</i> leads to a reduction in cortical progenitor cell pool and a decrease in cortical thickness. by Jian Zhang (1682)

A pair of RMVMR plots using two exposures presented for illustration. by Wes Spiller (13229484)